A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †

The current study aims to evaluate whether prophylactic anticoagulation using argatroban or an increased dose of unfractionated heparin (UFH) is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant (HR) patients. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachler, Mirjam, Hell, Tobias, Bösch, Johannes, Treml, Benedikt, Schenk, Bettina, Treichl, Benjamin, Friesenecker, Barbara, Lorenz, Ingo, Stengg, Daniel, Hruby, Stefan, Wallner, Bernd, Oswald, Elgar, Ströhle, Mathias, Niederwanger, Christian, Irsara, Christian, Fries, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230377/
https://www.ncbi.nlm.nih.gov/pubmed/32244368
http://dx.doi.org/10.3390/jcm9040963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230377/
https://www.ncbi.nlm.nih.gov/pubmed/32244368
http://dx.doi.org/10.3390/jcm9040963

Ejemplares similares